Related Experiment Video

Updated: Jun 9, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

An update on endometrial cancer

Todd Boren, David Miller

    Texas Medicine
    |September 3, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
    05:52

    Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

    Published on: August 19, 2021

    Related Experiment Videos

    Last Updated: Jun 9, 2026

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
    09:48

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

    Published on: September 12, 2019

    Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
    05:52

    Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

    Published on: August 19, 2021

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Correction: Grant et al. Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma. Cancers 2025, 17, 3883.

    Cancers·2026

    Variations in Perinatal Interventions and Outcomes Among Active-Duty Service Women in the U.S. Military Health System.

    Journal of women's health (2002)·2025

    Anger-Related Affect and Suicidal Thoughts and Behaviors: A Systematic Review and Meta-Analysis.

    Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association·2025

    Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma.

    Cancers·2025

    What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Review.

    JCO oncology practice·2025

    From reservoir to rendezvous: the journey of sperm through the oviduct.

    Reproduction, fertility, and development·2025

    Commentary: This Is Not a Drill.

    Texas medicine·2021

    Healthy Determination: Texas Physicians are Finding Better Ways to Address Their Patients' Social Determinants of Health.

    Texas medicine·2021

    Going Local: Accountable Health Organizations Could Help Combat Social Disparities at the Local Level.

    Texas medicine·2021

    Data Driven: Medicaid's Inspector General Focuses on Fraud Prevention, Not Just Prosecution.

    Texas medicine·2021

    Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).

    Texas medicine·2021

    Obstacles to Clear.

    Texas medicine·2021

    Expanding the Horizon of CAR-T Cell Therapy: Present Obstacles and New Strategies for Future CARs in Solid Tumors.

    Anti-cancer agents in medicinal chemistry·2026

    Radical Hysterectomy for Non-Endometrioid Endometrial Cancer With Cervical Involvement: A Retrospective Cohort Study.

    Journal of surgical oncology·2026

    Ischemic Postconditioning in Patients With Acute Stroke With Successful Recanalization After Endovascular Therapy: A Pilot Randomized Controlled Trial.

    Stroke·2026

    Depth-sensitive optical property characterization using multi-frequency laparoscopic spatial frequency domain imaging.

    Biomedical optics express·2026

    Metabolomic and inflammatory signatures in congenital hypothyroidism: a longitudinal analysis of levothyroxine response.

    Frontiers in endocrinology·2026

    Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) Monitoring of Rapidly Progressive Low-Risk Cutaneous Melanoma: A Case Report of Durable Response to Combined Stereotactic Body Radiotherapy (SBRT) and Immunotherapy.

    Cureus·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us